术中快速分子诊断在胶质瘤精准手术中的应用:模拟世界卫生组织中枢神经系统肿瘤第五版整合诊断
研究开发了自动整合基因检测系统(AIGS)用于胶质瘤术中检测,对105例样本和37例术中样本检测IDH1突变的准确率均为100%,盲法评估显示AIGS提供的分子信息使病理医师术中诊断准确率提高16.2%,并对5例IDH阳性患者确定了分子边界。
要点
- AIGS检测IDH1突变与二代测序相比,105例样本和37例术中样本准确率均为100%。
- AIGS提供的分子信息使胶质瘤术中诊断准确率提高16.2%。
- 利用多点同步检测技术为5例IDH阳性患者确定肿瘤分子边界,实现分子水平精准切除。
核心结论
- AIGS可在手术中快速准确提供分子信息,不仅提高术中病理诊断准确率,还为确定肿瘤边界提供分子依据以促进精准手术。
研究设计与样本
- 开发自动整合基因检测系统(AIGS)用于胶质瘤术中检测,分析105例胶质瘤样本的IDH1突变状态评估产品诊断价值。
- 对37例胶质瘤样本进行术中检测以评估实际可行性。
- 采用盲法评估检测技术对病理医师术中组织病理诊断准确率的影响,并综述术中分子诊断领域研究现状。
主要发现
- 与二代测序相比,AIGS检测IDH1在105例样本和37例术中样本中准确率均为100%。
- 盲法诊断结果两组比较,AIGS提供的分子信息使胶质瘤术中诊断准确率提高16.2%。
- 利用多点同步检测技术优势,为5例IDH阳性患者确定肿瘤分子边界,并在分子水平实现精准切除。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the advent of the molecular era, the diagnosis and treatment systems of glioma have also changed. A single histological type cannot be used for prognosis grade. Only by combining molecular diagnosis can precision medicine be realized. OBJECTIVE: To develop an automatic integrated gene detection system (AIGS) for intraoperative detection in glioma and to explore its positive role in intraoperative diagnosis and treatment. METHODS: We analyzed the isocitrate dehydrogenase 1 (IDH1) mutation status of 105 glioma samples and evaluated the product's potential value for diagnosis; 37 glioma samples were detected intraoperatively to evaluate the feasibility of using the product in an actual situation. A blinding method was used to evaluate the effect of the detection technology on the accuracy of intraoperative histopathological diagnosis by pathologists. We also reviewed the current research status in the field of intraoperative molecular diagnosis. RESULTS: Compared with next-generation sequencing, the accuracy of AIGS in detecting IDH1 was 100% for 105 samples and 37 intraoperative samples. The blind diagnostic results were compared between the 2 groups, and the molecular information provided by AIGS increased the intraoperative diagnostic accuracy of glioma by 16.2%. Using the technical advantages of multipoint synchronous detection, we determined the tumor molecular margins for 5 IDH-positive patients and achieved accurate resection at the molecular level. CONCLUSION: AIGS can quickly and accurately provide molecular information during surgery. This methodology not only improves the accuracy of intraoperative pathological diagnosis but also provides an important molecular basis for determining tumor margins to facilitate precision surgery.
引用
- Xue H, Han Z, Li H, et al. Application of Intraoperative Rapid Molecular Diagnosis in Precision Surgery for Glioma: Mimic the World Health Organization CNS5 Integrated Diagnosis. Neurosurgery. 2022. PMID: 36607719. doi:10.1227/neu.0000000000002260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。